Breaking News Instant updates and real-time market news.

TRU

TransUnion

$49.59

-0.11 (-0.22%)

, EFX

Equifax

$108.81

-1.69 (-1.53%)

07:30
10/13/17
10/13
07:30
10/13/17
07:30

TransUnion price target raised to $56 from $48 at SunTrust

SunTrust analyst Andrew W. Jeffrey raised his price target on TransUnion (TRU), saying that he is "increasingly convinced" that the government will not implement legislation or regulations that will change the ratings agencies' businesses. The agencies' "central roles in the consumer credit ecosystem" make such a development unlikely, according to the analyst. Jeffrey views TransUnion as the best positioned name in the space, due to what he sees as its "next-gen software, differentiated solutions, proprietary data, strong management and first mover advantage in Consumer Indirect." The analyst believes that the latter business will be boosted by the Equifax (EFX) breach. He keeps a Buy rating on TransUnion.

TRU

TransUnion

$49.59

-0.11 (-0.22%)

EFX

Equifax

$108.81

-1.69 (-1.53%)

  • 22

    Oct

  • 27

    Oct

  • 14

    Dec

TRU TransUnion
$49.59

-0.11 (-0.22%)

09/06/17
09/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Caterpillar (CAT) initiated with a Neutral at Seaport Global. 2. Liberty Global (LBTYA) initiated with a Buy at Deutsche Bank. 3. TransUnion (TRU) initiated with a Buy at SunTrust. 4. Inovio (INO) initiated with a Buy at Citi. 5. e.l.f. Beauty (ELF) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/08/17
DBAB
09/08/17
NO CHANGE
Target $160
DBAB
Buy
Equifax shares could close down 10% on breach, says Deutsche Bank
Deutsche Bank analyst Kevin McVeigh believes shares of Equifax (EFX) could close down 10% today after the company disclosed a security breach potentially impacting up to 143M consumers. The stock in premarket trading is down 13%, or $18.72, to $124.00. The analyst says that while difficult to quantify, his best effort suggests the financial impact could be in the range of $300M-$400M, which reflects the costs for credit monitoring, regulatory fines and penalties. Keith recommends waiting for Equifax shares to settle before accumulating fresh positions. The analyst, however, recommends buying TransUnion (TRU) on any selloff in sympathy to Equifax. He thinks TransUnion could trade down 3%-5% today before rebounding. Keith has a Buy rating on Equifax with a $160 price target.
09/14/17
LEHM
09/14/17
NO CHANGE
Target $115
LEHM
Overweight
Barclays cuts Equifax target, says further downside 'feels limited'
Barclays analyst Manav Patnaik lowered his price target for Equifax (EFX) shares to $115 but keeps an Overweight rating on the name. The stock closed yesterday down 15%, or $16.91, to $98.99. The analyst lowered his valuation multiple for the stock saying there are few, if any, positive catalysts over the near term as investors continue to digest the data breach. Patnaik, however, believes downside in the stock from current levels "feels limited." Regarding TransUnion (TRU), the analyst raised his price target for the shares to $50 from $48 and says he's a buyer on any further weakness. By all indications, the hack was an Equifax-specific event, Patnaik tells investors in a research note. After meeting with management, he believes TransUnion's fundamentals remain "very strong." The analyst maintains an Overweight rating on the shares.
09/15/17
09/15/17
NO CHANGE

SunTrust lowers Equifax, TransUnion price targets but advises buying stocks
SunTrust analyst Andrew Jeffrey cut his price target on Equifax (EFX) to $110 from $155 and lowered his price target on TransUnion (TRU) to $48 from $54. As reasons for the reductions, he cited increased competition from free credit monitoring programs and the risk of share loss in the wake of the Equifax data breach. However, he believes that both stocks reflect an "overstated" risk of negative legislative and/or regulatory changes. Jeffrey does not expect governments to create "barriers to complete and comprehensive data access," since, according to the analyst, lenders and many service providers rely on the data generated by the credit bureaus. He recommends buying both stocks.
EFX Equifax
$108.81

-1.69 (-1.53%)

10/03/17
JPMS
10/03/17
NO CHANGE
JPMS
Overweight
Political theatrics aside, JPMorgan expects reasonable credit bureau reform
Former Equifax CEO Rick Smith's testimony in front of Congress today will bring a fair amount of political theatrics, but ultimately, any regulatory changes for the credit bureau industry is likely to be "reasonable and manageable," JPMorgan analyst Andrew Steinerman tells investors in a research note. The analyst keeps an Overweight rating on shares of Equifax.
10/06/17
WELS
10/06/17
NO CHANGE
Target $127
WELS
Outperform
Wells Fargo reiterates Outperform on Equifax after Congressional testimony
Wells Fargo analyst William Warmington reiterates an Outperform rating on Equifax with a $127 price target following three days of Congressional testimony by former CEO Rick Smith. The legislative proposals discussed were either high-probability/low-impact, like requiring companies meet minimum cybersecurity standards and have a reaction plan in event of a breach,or low-probability/high-impact, like allowing consumers to opt out of having Equifax track their data and mandatory per-account fines for data breaches, Warmington tells investors in a research note. The analyst expects investor focus to shift to Equifax's preliminary 2018 guidance on its upcoming Q3 earnings call. He thinks the company's long-term growth model remains intact and introduced above-consensus 2019 revenue and earnings per shares estimates of $3.77B and $6.80. Many investors expect 2018 to be a "transition year" with revenue and costs impacted by the breach, Warmington writes.
10/09/17
COWN
10/09/17
DOWNGRADE
Target $31
COWN
Underperform
Symantec downgraded to Underperform at Cowen
As reported previously, Cowen analyst Gregg Moskowitz downgraded Symantec (SYMC) to Underperform from Market Perform as he believes the recent spike in its price following the disclosure of the Equifax (EFX) breach is overdone. He also said its organic growth has been sluggish, its valuation is no longer cheap, and next-gen vendors are gaining traction. Moskowitz maintained his $31 price target on Symantec shares.
10/13/17
RHCO
10/13/17
NO CHANGE
RHCO
Equifax price target raised to $125 from $110 at SunTrust
SunTrust analyst Andrew W. Jeffrey raised his price target on Equifax as he believes that investors will begin to focus on what he sees as the company's "sustainable earnings power" and the likely acceleration of its growth in 2019. The analyst recommends buying the stock on any further weakness and keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

07:56
02/22/18
02/22
07:56
02/22/18
07:56
Conference/Events
The FTC to hold a meeting »

Open Commission Meeting…

HASI

Hannon Armstrong

$20.77

-0.22 (-1.05%)

07:55
02/22/18
02/22
07:55
02/22/18
07:55
Recommendations
Hannon Armstrong analyst commentary  »

Hannon Armstrong weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$125.67

-0.35 (-0.28%)

07:55
02/22/18
02/22
07:55
02/22/18
07:55
Recommendations
Workday analyst commentary  »

Workday price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 28

    Feb

NFX

Newfield Exploration

$23.20

-2.53 (-9.83%)

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Upgrade
Newfield Exploration rating change  »

Newfield Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CNP

CenterPoint Energy

$26.23

-0.5 (-1.87%)

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Hot Stocks
CenterPoint targets FY18 Energy Services operating income $55M-$65M »

Says capital rate base…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 19

    Mar

  • 06

    Apr

07:54
02/22/18
02/22
07:54
02/22/18
07:54
Conference/Events
CFA Society of Milwaukee to hold a luncheon discussion »

Bill Stone, CMT of PNC…

07:53
02/22/18
02/22
07:53
02/22/18
07:53
Conference/Events
STAT Plus to hold webinar »

STAT Senior Science…

AAOI

Applied Optoelectronics

$34.55

1.22 (3.66%)

07:51
02/22/18
02/22
07:51
02/22/18
07:51
Recommendations
Applied Optoelectronics analyst commentary  »

Applied Optoelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Mar

  • 29

    Mar

07:51
02/22/18
02/22
07:51
02/22/18
07:51
General news
Futures pointing to higher open »

Stock futures have…

07:51
02/22/18
02/22
07:51
02/22/18
07:51
Conference/Events
The FCC to hold a commission meeting »

Open Commission Meeting…

07:50
02/22/18
02/22
07:50
02/22/18
07:50
Conference/Events
Federal Reserve Bank of New York President speaks at press briefing »

New York Federal Reserve…

STMP

Stamps.com

$184.95

-5.1 (-2.68%)

07:49
02/22/18
02/22
07:49
02/22/18
07:49
Recommendations
Stamps.com analyst commentary  »

Stamps.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 23

    May

LNKD

Acquired by MSFT

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Conference/Events
Detroit Economic Club to hold a breakfast meeting »

Brenda Meller, Owner and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

MCS

Marcus

$26.10

1 (3.98%)

07:48
02/22/18
02/22
07:48
02/22/18
07:48
Earnings
Marcus reports Q4 EPS $1.21, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 23

    May

PHX

Panhandle Oil & Gas

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Initiation
Panhandle Oil & Gas initiated  »

Panhandle Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 11

    Mar

CRM

Salesforce

$114.48

0.13 (0.11%)

07:47
02/22/18
02/22
07:47
02/22/18
07:47
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 28

    Feb

07:46
02/22/18
02/22
07:46
02/22/18
07:46
Conference/Events
FDA to co-host a workshop »

The FDA, American…

MLNX

Mellanox

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Recommendations
Mellanox analyst commentary  »

Mellanox price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

RDHL

RedHill Biopharma

$6.26

0.05 (0.81%)

07:44
02/22/18
02/22
07:44
02/22/18
07:44
Earnings
RedHill Biopharma reports Q4 EPS (26c), consensus (60c) »

Reports Q4 revenue $2M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

07:43
02/22/18
02/22
07:43
02/22/18
07:43
Conference/Events
JPMorgan to hold a conference »

Korea Conference will be…

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees FY18 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Conference/Events
Deutsche Bank to hold a conference »

Indonesia Corporate Days…

ROKU

Roku

$51.10

-0.08 (-0.16%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Recommendations
Roku analyst commentary  »

Roku price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 21

    Mar

HSC

Harsco

$16.75

0.45 (2.76%)

07:42
02/22/18
02/22
07:42
02/22/18
07:42
Earnings
Breaking Earnings news story on Harsco »

Harsco sees Q1 adj. EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

AKBA

Akebia

$14.31

0.69 (5.07%)

, CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

07:41
02/22/18
02/22
07:41
02/22/18
07:41
Conference/Events
RBC Capital to hold a conference »

Global Healthcare…

AKBA

Akebia

$14.31

0.69 (5.07%)

CRSP

Crispr Therapeutics

$41.16

-0.45 (-1.08%)

RDUS

Radius Health

$37.71

-0.51 (-1.33%)

TYME

Tyme Technologies

$3.37

-0.06 (-1.75%)

HCA

HCA Healthcare

$100.35

-0.65 (-0.64%)

ARAY

Accuray

MDRX

Allscripts

$13.57

0.335 (2.53%)

ABEO

Abeona Therapeutics

$11.70

0.1 (0.86%)

SGEN

Seattle Genetics

$54.11

-0.05 (-0.09%)

INSY

Insys Therapeutics

$7.93

0.34 (4.48%)

SPPI

Spectrum

$20.51

0.21 (1.03%)

SPH

Suburban Propane

$24.10

-0.2 (-0.82%)

AIMT

Aimmune

$32.21

-2.75 (-7.87%)

DEPO

Depomed

$7.46

0.07 (0.95%)

KTWO

K2M Group

$19.09

-0.01 (-0.05%)

INOV

Inovalon

$11.68

-1.025 (-8.07%)

IMMU

Immunomedics

$16.38

0.16 (0.99%)

OVID

Ovid Therapeutics

$6.83

-0.2 (-2.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 11

    Mar

  • 14

    Mar

  • 01

    May

  • 03

    May

  • 22

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.